LIPOTROPIC GOLD — Class II drug recall D-1404-2014
Terminated recall by John W Hollis Inc, reported 2014-06-25, distributed nationwide. Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable produc
| Recall number | D-1404-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | John W Hollis Inc, Nashville, TN, United States |
| Recall initiated | 2014-05-12 |
| Classified | 2014-06-18 |
| Reported by FDA | 2014-06-25 |
| Terminated | 2014-07-02 |
| Distributed | Nationwide (US) |
| Quantity | 80 ml |
| Reason classes | sterility |
| Lot numbers | 2571 |
| Expiration dates | 2014-09-23 |
Product
LIPOTROPIC GOLD, Each mL contains: Levocarnitine 5 mg, Thiamine 50 mg, Riboflavin-5 phosphate 5mg, Niacinimide 50mg, Calcium Pantothenate 5 mg, Cyanocobalamin 1mg, Methionine 12.5mg, Choline 25mg, Inositol 25 mg, Sterile Water For injection, JOHN HOLLIS Pharmacist, Inc,110 20th Avenue N, Nashville, TN 37203, 615-327-3234
Reason for recall
Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1404-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.